The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
102531326 10253132 6 F 1996 20160629 20140623 20160705 EXP US-GLAXOSMITHKLINE-A1077949A GLAXOSMITHKLINE 54.99 YR M Y 0.00000 20160705 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
102531326 10253132 1 PS LAMICTAL LAMOTRIGINE 1 Oral 500 MG, BID U UNKNOWN 20241 500 MG TABLET BID
102531326 10253132 2 SS LAMICTAL LAMOTRIGINE 1 25 MG, U U 20241 25 MG TABLET
102531326 10253132 3 SS LAMICTAL LAMOTRIGINE 1 100 MG, UNK U 20241 100 MG TABLET
102531326 10253132 4 SS LAMICTAL LAMOTRIGINE 1 300 MG, QD U 20241 300 MG TABLET QD
102531326 10253132 5 SS LAMICTAL LAMOTRIGINE 1 550 MG, QD U 20241 550 MG TABLET QD
102531326 10253132 6 SS LAMICTAL LAMOTRIGINE 1 UNK, U, 100 MG AND 25 MG TABLETS U 20241 TABLET
102531326 10253132 7 SS TYLENOL ACETAMINOPHEN 1 Oral 1000 MG, PRN Y Y 0 1000 MG
102531326 10253132 8 SS VOLTAREN DICLOFENAC SODIUM 1 UNK, U U 0
102531326 10253132 9 SS NAPROXEN. NAPROXEN 1 UNK, U U 0
102531326 10253132 10 SS TYLENOL PM ACETAMINOPHENDIPHENHYDRAMINE 1 UNK, U U 0
102531326 10253132 11 C KLONOPIN CLONAZEPAM 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
102531326 10253132 1 Temporal lobe epilepsy
102531326 10253132 2 Seizure
102531326 10253132 7 Sleep disorder
102531326 10253132 8 Product used for unknown indication
102531326 10253132 9 Product used for unknown indication
102531326 10253132 10 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
102531326 10253132 HO
102531326 10253132 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
102531326 10253132 Appendicectomy
102531326 10253132 Brain oedema
102531326 10253132 Brain operation
102531326 10253132 Carpal tunnel syndrome
102531326 10253132 Cerebral lobotomy
102531326 10253132 Divorced
102531326 10253132 Drug hypersensitivity
102531326 10253132 Drug ineffective
102531326 10253132 Drug interaction
102531326 10253132 Fall
102531326 10253132 Fatigue
102531326 10253132 Generalised tonic-clonic seizure
102531326 10253132 Hernia repair
102531326 10253132 Insomnia
102531326 10253132 Partial seizures
102531326 10253132 Peripheral nerve lesion
102531326 10253132 Renal stone removal
102531326 10253132 Shoulder operation
102531326 10253132 Spinal fusion surgery
102531326 10253132 Spinal operation
102531326 10253132 Surgery
102531326 10253132 Upper limb fracture

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
102531326 10253132 1 199604 0
102531326 10253132 2 2014 0
102531326 10253132 7 200408 0